Earnings Data
Report Date
Aug 18, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with significant revenue growth and successful debt reduction. The company's strategic initiatives, such as the white labeling strategy, are expected to drive future growth without additional capital requirements. However, challenges remain with capital-intensive product lines and existing debt obligations.Company Guidance
Revenue Growth in Core Business
Evome generated $10.5 million in revenue for Q2 2024, with $6.1 million from the core business, Biodex Rehab. This represents a 59% revenue growth compared to Q1 2024.
Positive Adjusted EBITDA
Evome posted a positive adjusted EBITDA of $421,000 in Q2 2024, marking an improvement of $1.7 million over Q1 2024 and $1.4 million year-over-year compared to Q2 2023.
Debt Reduction
Evome reduced its debt by $2.7 million in Q2 2024, including $2.6 million from acquisition debt and $200,000 from the company's credit line. An additional reduction of $900,000 to the credit line was paid down in July 2024.
Strong Cash Position
Evome ended Q2 2024 with over $1 million in cash on hand, indicating improved liquidity compared to previous quarters.
White Labeling Strategy for Growth
Evome plans to expand the Biodex brand through a white labeling strategy, enabling it to offer new products without significant capital expenditure, which is expected to generate additional revenue in 2025.
TSE:EVMT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:EVMT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 19, 2026 | C$0.01 | C$0.01 | 0.00% |
Apr 06, 2026 | C$0.01 | C$0.01 | 0.00% |
Nov 12, 2025 | C$0.01 | C$0.01 | 0.00% |
Aug 19, 2025 | C$0.01 | C$0.01 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Salona Global Medical Device (TSE:EVMT) report earnings?
Salona Global Medical Device (TSE:EVMT) is schdueled to report earning on Aug 18, 2026, After Close (Confirmed).
What is Salona Global Medical Device (TSE:EVMT) earnings time?
Salona Global Medical Device (TSE:EVMT) earnings time is at Aug 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:EVMT EPS forecast?
Currently, no data Available